Huangqi Guizhi Wuwu Decoction Can Prevent and Treat Oxaliplatin-induced Neuropathic Pain by TNFα/IL-1β/IL-6/MAPK/NF-kB Pathway

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2022 Jun 27

PMID 35759577

Authors

Mingzhu Li

Zheng Li

Xiande Ma

Shengbo Jin

Yang Cao

Xuebing Wang

Jian Zhao

Jianbo Wang

Xin Wang

Jian Xu

Affiliations

Soon will be listed here.

Abstract

Objective: This study explored the effects and mechanisms of Huangqi Guizhi Wuwu Decoction on chemotherapy-induced neuropathic pain (CINP).

Methods: Bodyweight and related behavioral testing of the rat model were utilized to investigate the effects of Huangqi Guizhi Wuwu Decoction on CINP. ELISA was used to measure the levels of TNF-α, IL-1β, and IL-6, in the serum of chronic CINP rats. Immunohistochemistry and Western blot analysis were performed to detect the expression of MAPK pathway related-proteins namely ERK1/2, p38, and JNK, and the expression of downstream essential proteins such as c-Fos, CREB, and NF-κB.

Results: Body weight and related behavioral testing of the rat model suggests that Huangqi Guizhi Wuwu Decoction can improve the slow weight gain of oxaliplatin-induced chronic CINP model rats and effectively prevent and treat oxaliplatin-induced regular CIPN rat model of hyperalgesia. It can also oppress the mechanical pain threshold, cold pain threshold, and heat pain threshold decreased. Furthermore, by ELISA, immunohistochemistry, and western blot analysis, we found that Huangqi Guizhi Wuwu Decoction can down-regulate the levels of TNF-α, IL-1β, and IL-6 in the serum of chronic CINP rats induced by oxaliplatin. It also suppresses the expression of MAPK pathway related-proteins ERK1/2, p38, and JNK. This results in a decrease in the expression of downstream essential proteins, c-Fos, CREB, and Nf-κB.

Conclusions: In conclusion, we found that Huangqi Guizhi Wuwu Decoction can combat nerve cell injury, reduce pain sensitization, and prevent and repair the damage of nerve cells in the oxaliplatin CINP model rats via TNFα/IL-1β/IL-6/MAPK/NF-kB pathway.

Citing Articles

A review of L.: a valuable plant with profound biological significance.

Yang A, Kong L, You Z, Li X, Guan J, Li F Front Pharmacol. 2025; 15:1521040.

PMID: 39902075 PMC: 11788583. DOI: 10.3389/fphar.2024.1521040.

TangBi Formula for Painful Diabetic Distal Symmetric Polyneuropathy: A Multicenter, Randomized, Double-Blind, Placebo-Controlled and Parallel-Group Trial.

Zhao X, An X, Cui Y, Dong L, Fang Z, Zheng Z J Diabetes. 2025; 17(1):e70045.

PMID: 39757352 PMC: 11702395. DOI: 10.1111/1753-0407.70045.

A comprehensive review of traditional Chinese medicine in treating neuropathic pain.

Hu N, Liu J, Luo Y, Li Y Heliyon. 2024; 10(17):e37350.

PMID: 39296122 PMC: 11407996. DOI: 10.1016/j.heliyon.2024.e37350.

Study on the Efficacy and Safety of the Huangqi Guizhi Wuwu Decoction in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Meta-Analysis of 32 Randomized Controlled Trials.

Yang X, Zhang X, Xia Y, Fu J, Lian X, Liang X J Pain Res. 2024; 17:2605-2628.

PMID: 39139997 PMC: 11319928. DOI: 10.2147/JPR.S466658.

Huangqi Guizhi Wuwu Decoction Improves Inflammatory Factor Levels in Chemotherapy-induced Peripheral Neuropathy by Regulating the Arachidonic Acid Metabolic Pathway.

Wang S, Du X, Yan G, Yang L, Sun H, Zhang X Curr Pharm Des. 2024; 30(34):2701-2717.

PMID: 39092641 DOI: 10.2174/0113816128308622240709102830.

References

Neurath M, Pettersson S, Meyer zum Buschenfelde K, Strober W . Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996; 2(9):998-1004. DOI: 10.1038/nm0996-998. View

Kanat O, Ertas H, Caner B . Platinum-induced neurotoxicity: A review of possible mechanisms. World J Clin Oncol. 2017; 8(4):329-335. PMC: 5554876. DOI: 10.5306/wjco.v8.i4.329. View

Flatters S, Dougherty P, Colvin L . Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. Br J Anaesth. 2017; 119(4):737-749. DOI: 10.1093/bja/aex229. View

Screnci D, McKeage M, Galettis P, Hambley T, Palmer B, Baguley B . Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. Br J Cancer. 2000; 82(4):966-72. PMC: 2374394. DOI: 10.1054/bjoc.1999.1026. View

Xiao W, Zheng H, Bennett G . Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience. 2011; 203:194-206. PMC: 3273641. DOI: 10.1016/j.neuroscience.2011.12.023. View

Yamamoto K, Chiba N, Chiba T, Kambe T, Abe K, Kawakami K . Transient receptor potential ankyrin 1 that is induced in dorsal root ganglion neurons contributes to acute cold hypersensitivity after oxaliplatin administration. Mol Pain. 2015; 11:69. PMC: 4644342. DOI: 10.1186/s12990-015-0072-8. View

Chen T, Cao L, Dong W, Luo P, Liu W, Qu Y . Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK/ERK pathway. Neurochem Res. 2012; 37(5):983-90. DOI: 10.1007/s11064-011-0691-z. View

Ma J, Shi M, Zhang X, Liu X, Chen J, Zhang R . GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats. Int J Mol Med. 2018; 41(5):2977-2985. DOI: 10.3892/ijmm.2018.3509. View

Kerckhove N, Collin A, Conde S, Chaleteix C, Pezet D, Balayssac D . Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review. Front Pharmacol. 2017; 8:86. PMC: 5323411. DOI: 10.3389/fphar.2017.00086. View

10.

Ashlin T, Buckley M, Salter R, Johnson J, Kwan A, Ramji D . The anti-atherogenic cytokine interleukin-33 inhibits the expression of a disintegrin and metalloproteinase with thrombospondin motifs-1, -4 and -5 in human macrophages: Requirement of extracellular signal-regulated kinase, c-Jun N-terminal kinase.... Int J Biochem Cell Biol. 2013; 46:113-23. PMC: 3928996. DOI: 10.1016/j.biocel.2013.11.008. View

11.

Liang F, Liu M, Fu X, Zhou X, Chen P, Han F . Dexmedetomidine attenuates neuropathic pain in chronic constriction injury by suppressing NR2B, NF-κB, and iNOS activation. Saudi Pharm J. 2017; 25(4):649-654. PMC: 5447440. DOI: 10.1016/j.jsps.2017.04.039. View

12.

Huh Y, Ji R, Chen G . Neuroinflammation, Bone Marrow Stem Cells, and Chronic Pain. Front Immunol. 2017; 8:1014. PMC: 5567062. DOI: 10.3389/fimmu.2017.01014. View

13.

Goldberg R, Sargent D, Morton R, Fuchs C, Ramanathan R, Williamson S . A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2003; 22(1):23-30. DOI: 10.1200/JCO.2004.09.046. View

14.

Chen X, Wu S, Chen C, Xie B, Fang Z, Hu W . Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury. J Neuroinflammation. 2017; 14(1):143. PMC: 5525354. DOI: 10.1186/s12974-017-0917-3. View

15.

Cheng X, Liu H, Wang Q, Huo J, Wang X, Cao P . Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective. Front Pharmacol. 2015; 6:234. PMC: 4615942. DOI: 10.3389/fphar.2015.00234. View

16.

Pignata S, De Placido S, Biamonte R, Scambia G, Di Vagno G, Colucci G . Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. BMC Cancer. 2006; 6:5. PMC: 1361775. DOI: 10.1186/1471-2407-6-5. View

17.

Tao L, Li D, Liu H, Jiang F, Xu Y, Cao Y . Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway. Brain Res Bull. 2018; 140:154-161. DOI: 10.1016/j.brainresbull.2018.04.008. View

18.

Fallon M . Neuropathic pain in cancer. Br J Anaesth. 2013; 111(1):105-11. DOI: 10.1093/bja/aet208. View

19.

Ling B, Authier N, Balayssac D, Eschalier A, Coudore F . Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat. Pain. 2006; 128(3):225-234. DOI: 10.1016/j.pain.2006.09.016. View

20.

Nishimoto S, Kusakabe M, Nishida E . Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development. EMBO Rep. 2005; 6(11):1064-9. PMC: 1371025. DOI: 10.1038/sj.embor.7400515. View